243 related articles for article (PubMed ID: 26132584)
1. The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis.
Sachdeva KS; Raizada N; Gupta RS; Nair SA; Denkinger C; Paramasivan CN; Kulsange S; Thakur R; Dewan P; Boehme C; Arinaminpathy N
PLoS One; 2015; 10(7):e0131438. PubMed ID: 26132584
[TBL] [Abstract][Full Text] [Related]
2. Disease control implications of India's changing multi-drug resistant tuberculosis epidemic.
Suen SC; Bendavid E; Goldhaber-Fiebert JD
PLoS One; 2014; 9(3):e89822. PubMed ID: 24608234
[TBL] [Abstract][Full Text] [Related]
3. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
Sachdeva KS; Raizada N; Sreenivas A; Van't Hoog AH; van den Hof S; Dewan PK; Thakur R; Gupta RS; Kulsange S; Vadera B; Babre A; Gray C; Parmar M; Ghedia M; Ramachandran R; Alavadi U; Arinaminpathy N; Denkinger C; Boehme C; Paramasivan CN
PLoS One; 2015; 10(5):e0126065. PubMed ID: 25996389
[TBL] [Abstract][Full Text] [Related]
4. The importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission model.
Salje H; Andrews JR; Deo S; Satyanarayana S; Sun AY; Pai M; Dowdy DW
PLoS Med; 2014 Jul; 11(7):e1001674. PubMed ID: 25025235
[TBL] [Abstract][Full Text] [Related]
5. Drug sensitivity patterns in Xpert-positive spinal tuberculosis: an observational study of 252 patients.
Upadhyay M; Patel J; Kundnani V; Ruparel S; Patel A
Eur Spine J; 2020 Jul; 29(7):1476-1482. PubMed ID: 32055960
[TBL] [Abstract][Full Text] [Related]
6. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
Ershova JV; Volchenkov GV; Somova TR; Kuznetsova TA; Kaunetis NV; Kaminski D; Demikhova OV; Chernousova LN; Vasilyeva IA; Kerr EM; Cegielski JP; Kurbatova EV
BMC Infect Dis; 2020 Jul; 20(1):543. PubMed ID: 32711457
[TBL] [Abstract][Full Text] [Related]
7. Tackling drug-resistant tuberculosis: we need a critical synergy of product and process innovations.
Talbot EA; Pai M
Int J Tuberc Lung Dis; 2019 Jul; 23(7):774-782. PubMed ID: 31439108
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Multi-Drug Resistant Tuberculosis among Tuberculosis Patients Attending Chest Clinics in Osun-State, Nigeria.
Oyedeji GJ; Adeyemo C; Dissou A; Abiodun T; Alli OAT; Onaolapo OJ; Onaolapo AY; Adesiji Y; Olowe OA
Curr Pharm Biotechnol; 2020; 21(10):939-947. PubMed ID: 32101120
[TBL] [Abstract][Full Text] [Related]
9. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
Sharma SK; Chaubey J; Singh BK; Sharma R; Mittal A; Sharma A
Int J Tuberc Lung Dis; 2017 Oct; 21(10):1112-1117. PubMed ID: 28911354
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
[TBL] [Abstract][Full Text] [Related]
11. Impact of rapid molecular diagnostic tests on time to treatment initiation and outcomes in patients with multidrug-resistant tuberculosis, Tamil Nadu, India.
Nair D; Navneethapandian PD; Tripathy JP; Harries AD; Klinton JS; Watson B; Sivaramakrishnan GN; Reddy DS; Murali L; Natrajan M; Swaminathan S
Trans R Soc Trop Med Hyg; 2016 Sep; 110(9):534-541. PubMed ID: 27738284
[TBL] [Abstract][Full Text] [Related]
12. High pre-diagnosis attrition among patients with presumptive MDR-TB: an operational research from Bhopal district, India.
Shewade HD; Kokane AM; Singh AR; Verma M; Parmar M; Chauhan A; Chahar SS; Tiwari M; Khan SN; Gupta V; Tripathy JP; Nagar M; Singh SK; Mehra PK; Kumar AM
BMC Health Serv Res; 2017 Apr; 17(1):249. PubMed ID: 28376789
[TBL] [Abstract][Full Text] [Related]
13. Survey of tuberculosis drug resistance among Tibetan refugees in India.
Salvo F; Dorjee K; Dierberg K; Cronin W; Sadutshang TD; Migliori GB; Rodrigues C; Trentini F; Di Serio C; Chaisson R; Cirillo DM
Int J Tuberc Lung Dis; 2014 Jun; 18(6):655-62. PubMed ID: 24903934
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P
Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India.
Jain A; Singh PK; Chooramani G; Dixit P; Malhotra HS
Int J Tuberc Lung Dis; 2016 Jul; 20(7):870-5. PubMed ID: 27287637
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of genotype MTBDRplus line probe assay in detection of rifampicin and isoniazid resistance in comparison to solid culture drug susceptibility testing in a tertiary care centre of western Uttar Pradesh.
Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M
Indian J Med Microbiol; 2017; 35(4):568-574. PubMed ID: 29405151
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis.
Dowdy DW; van't Hoog A; Shah M; Cobelens F
Int J Tuberc Lung Dis; 2014 Jun; 18(6):647-54. PubMed ID: 24903933
[TBL] [Abstract][Full Text] [Related]
18. Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic.
Udwadia ZF; Tornheim JA; Ganatra S; DeLuca A; Rodrigues CS; Gupta A
BMC Infect Dis; 2019 Jan; 19(1):94. PubMed ID: 30691407
[TBL] [Abstract][Full Text] [Related]
19. Comparing the impact of genotypic based diagnostic algorithm on time to treatment initiation and treatment outcomes among drug-resistant tuberculosis patients in Amhara region, Ethiopia.
Kassa GM; Merid MW; Muluneh AG; Wolde HF
PLoS One; 2021; 16(2):e0246938. PubMed ID: 33600409
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant tuberculosis in Viet Nam.
Dang TM; Nguyen TN; Wolbers M; Vo SK; Hoang TT; Nguyen HD; To MH; Vuong MB; Nguyen TP; Tran VQ; Nguyen TB; Vo TH; Nguyen TN; Dai VH; Phan TH; Nguyen HD; Farrar J; Caws M
BMC Infect Dis; 2012 Mar; 12():49. PubMed ID: 22375832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
